According to the latest report by IMARC Group, titled “Tissue Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The global tissue banking market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.65% during 2023-2028.
Tissue banking represents the process of collecting, preparing, and preserving transplantable human tissues for potential therapeutic uses. This system is run by technical experts and skilled personnel who focus on preserving the living tissues for a prolonged period of time for later usage. The tissues obtained are generally preserved in low-temperature storage containers that are widely used for replacing and healing the affected or lost tissues of the patients. They are also utilized to treat spinal cord injuries, repair damaged heart muscles, heal skin from severe burns, etc. Consequently, tissue banking is gaining extensive traction across the globe.
Request Free Sample Report: https://www.imarcgroup.com/tissue-banking-market/requestsample
Tissue Banking Market Trends and Drivers:
The rising prevalence of injuries in the spinal cord and damaged heart muscles is primarily driving the tissue banking market. Additionally, the growing incidences of missing or damaged tissues and continuous technological advancements in the healthcare industry and the tissue collecting and preserving process are further catalyzing the market growth. Besides this, the elevating cases of chronic diseases among individuals are propelling the utilization of tissue banks for the transplantation of bones, corneas, and tendons, which is acting as another significant growth-inducing factor. Moreover, extensive investments by private and public agencies for improvements in the field of tissue engineering are positively influencing the global market. Apart from this, the expanding geriatric population and the increasing number of clinical trials and drug delivery procedures are also stimulating the market growth. Furthermore, the emerging trend of cosmetic surgeries, on account of the inflating per capita income levels, is anticipated to fuel the tissue banking market over the forecasted period.
Tissue Banking Market 2023-2028 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- AMS Biotechnology
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- Brooks Life Sciences Inc. (Brooks Automation Inc.)
- Eppendorf AG
- Merck KgaA
- PHC Corporation
- QIAGEN N.V.
- Sartorius AG
- Taylor-Wharton
- Thermo Fisher Scientific Inc.
- VWR International LLC (Avantor Inc).
The report has segmented the market on the basis on region, product, application, tissue type.
Breakup by Product:
- Equipment
- Cryopreservation Equipment
- Thawing Equipment
- Quality Control Equipment
- Others
- Media and Consumables
Breakup by Application:
- Therapeutics
- Medical Research
- Others
Breakup by Tissue Type:
- Cardiovascular Tissue
- Lung Tissue
- Kidney Tissue
- Pancreas Tissue
- Liver Tissue
- Eye Tissue
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/tissue-banking-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
